Our GeneTrails®  next-generation sequencing panels are customized to provide the key information on solid tumors in a cost-effective manner.
Showing Results 1 to 10 of 19.

ALK Mutation Analysis

  • Test Code:
    4023
  • Department:
  • Test Synonyms:
    ALK Resistance Mutations
View Test

BRAF Mutation Analysis

  • Test Code:
    4110
  • Department:
  • Test Synonyms:
    BRAF BRAF Gene Mutation (exon 15)
View Test

cKIT-GIST (may include exons 9,11,13,17) Mutation Analysis, reflexed to PDGFRA

  • Test Code:
    4199
  • Department:
  • Test Synonyms:
    KIT (cKIT) for Gastrointestinal stromal tumor (GIST) (exons 9, 11, 13, 17) reflexed to PDGFRA
View Test

EGFR Mutation Analysis

  • Test Code:
    4360
  • Department:
  • Test Synonyms:
    EGFR EGFR Gene Mutation (Exons 18, 19, 20 & 21)
View Test

GeneTrails Comprehensive Solid Tumor Panel

  • Test Code:
    5441
  • Department:
  • Test Synonyms:
    Solid Tumor Panel Version 3 ACVR1 AKT1 AKT2 AKT3 ALK AMER1 APC APLNR AR ARAF ARID1A ARID2 ASF1A ATM ATR ATRX AURKA AXIN1 B2M BAP1 BARD1 BRAF BRCA1 BRCA2 BRD4 BRIP1 BUB1B EMSY CASP8CCND1 CCND2 CCND3 CCNE1 CD274 (PD-L1) CDH1 CDK12 CDK4 CDK6 CDKN1B CDKN2A CHD4 CHEK1 CHEK2 CIC COL2A1 CTNNB1 DDR2 DDX11 DDX3X DICER1 EGFR EGLN1 EGLN2 EIF1AX EPAS1 ERBB2 ERBB3 ERBB4 ERCC2 ERCC3 ERCC5 ESR1 FAM175A FANCA FANCC FANCD2 FANCE FANCF FANCG FANCM FBXW7 FGF19 FGF3 FGF4 FGFR1 FGFR2 FGFR3 FGFR4 FH FUBP1 GATA3 GNA11 GNAQ GNAS H3F3A HIST1H3B HIST1H3C HLA-A HLA-B HLA-C HOXB13 HRAS IDH1 IDH2 IDO1 IDO2 IFNGR1 IFNGR2 INPP4B IRF1 JAK1 JAK2 KDR KEAP1 KIF1B KIT KLF4 KRAS LZTR1 MAP2K1 (MEK1) MAP2K2 (MEK2) MAP2K4 MAP3K1 MAPK1 MAX MC1R MDC1 MDH2 MDM2 MDM4 MEN1 MET MLH1 MLH3 MRE11A MSH2 MSH3 MSH6 MTAP MTOR MUTYH MYC MYCN MYOD1 NBN NDUFAB1 NF1 NF2 NRAS NTRK1 NTRK2 NTRK3 PALB2 PBRM1 PDCD1LG2 PDGFRA PIK3CA PIK3CB PIK3R1 PLAG1 PLCG1 PMS1 PMS2 POLE PPM1D PPP2R1A PPP6C PRKAR1A PRKCA PSMB5 PTCH1 PTEN PTPN11 PTPRB RAC1 RAD50 RAD51 RAD51B RAD51C RAD51D RAD52 RAD54L RAF1 RASA1 RB1 RECQL RET REV7 RHEB RICTOR RINT1 RIT1 RNF139 RNF43 ROS1 RPTOR RRAS SDHA SDHAF1 SDHAF2 SDHAF3 SDHAF4 SDHB SDHC SDHD SETD2 SF3B1 SMAD4 SMARCA2 SMARCA4 SMARCB1 SMARCE1 SMO SOCS1 SPEN SPOP STAG2 STAT3 STK11 SUFU TAP1 TAP2 TAPBP TCEB1 TERT TMEM127 TP53 TP53BP1 TRAF7 TSC1 TSC2 VHL XRCC1 YAP1 YES1
View Test

GeneTrails Solid Tumor Fusion Gene Panel

  • Test Code:
    4480
  • Department:
  • Test Synonyms:
    Fusion gene Gene fusion ALK ROS1
View Test

Glioma Microarray – Targeted Region Panel

  • Test Code:
    6515
  • Department:
  • Test Synonyms:
    Glioma array Glioma copy number analysis Glioma gene/targeted region
View Test

GNAQ and GNA11 Mutation Analysis

  • Test Code:
    4525
  • Department:
  • Test Synonyms:
    GNAQ GNA11 melanoma choroid uveal
View Test

H3F3A Mutation Analysis

  • Test Code:
    4810
  • Department:
  • Test Synonyms:
    Histone H3.3
View Test

IDH1 and IDH2 Mutation Analysis

View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More